Restoration of cardiomyocyte functional properties by angiotensin II receptor blockade in diabetic rats

Diabetes

Volumn 53, Issue 7, 2004, Pages 1927-1933

  Raimondi, Laura ^a   De Paoli, Petra ^a   Mannucci, Edoardo ^a   Lonardo, Giuseppe ^a   Sartiani, Laura ^a   Banchelli, Grazia ^a   Pirisino, Renato ^a   Mugelli, Alessandro ^a   Cerbai, Elisabetta ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Dept of Preclin/Clin Pharmacol ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; GLUCOSE; LOSARTAN; STREPTOZOCIN;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BETA ADRENERGIC STIMULATION; BODY WEIGHT; CARDIOMYOPATHY; CELL FUNCTION; CELL ISOLATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; GLUCOSE TRANSPORT; HEART DISEASE; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; MALE; MUSCLE CELL; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ACTION POTENTIALS; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; ELECTROPHYSIOLOGY; GLUCOSE; MALE; MYOCYTES, CARDIAC; RATS; RATS, WISTAR; RECEPTORS, ANGIOTENSIN; RECOVERY OF FUNCTION;

EID: 3042826527     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.7.1927     Document Type: Article

References (39)

1. Taegtmeyer H, McNulty P, Young ME: Adaptation and maladaptation of the heart in diabetes. I. General concepts. Circulation 105:1727-1733, 2002
2. Finck BN, Lehman JJ, Leone TC, Welch MJ, Bennett MJ, Kovacs A, Han X, Gross RW, Kozak R, Lopaschuk GD, Kelly DP: The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus. J Clin Invest 109:121-130, 2002
3. van der Vusse GJ, van Bilsen M, Glatz JF: Cardiac fatty acid uptake and transport in health and disease. Cardiovasc Res 45:279-293, 2000
4. Stanley WC, Lopaschuk GD, McCormack JG: Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res 34:25-33, 1997
5. Shimoni Y, Firek L, Severson D, Giles W: Short-term diabetes alters K+ currents in rat ventricular myocytes. Circ Res 74:620-628, 1994
6. Nishiyama A, Ishii DN, Backx PH, Pulford BE, Birks BR, Tamkun MM: Altered K+ channel gene expression in diabetic rat ventricle: isoform switching between Kv4.2 and Kv1.4. Am J Physiol 281:H1800-H1807, 2001
7. Young ME, McNulty P, Taegtmeyer H: Adaptation and maladaptation of the heart in diabetes. II. Potential mechanisms. Circulation 105:1861-1870, 2002
8. Dzau VJ: Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 37:1047-1052, 2001
9. Shekelle PG, Rich MW, Morton SC, Atkinson C, Tu W, Maglione M, Rhodes S, Barrett M, Fonarow GC, Greenberg B: Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. J Am Coll Cardiol 41:1529-1538, 2003
10. Gewaltig MT, Kojda G: Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovasc Res 55:250-260, 2002
11. Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham study. JAMA 241:2035-2038, 1979
12. Brown L, Wall D, Marchant C, Sernia C: Tissue-specific changes in angiotensin II receptors in streptozotocin-diabetic rats. J Endocrinol 154:355-362, 1997
13. Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B, Anversa P: Myocardial cell death in human diabetes. Circ Res 87:1123-1132, 2000
14. Fiordaliso F, Li B, Latini R, Sonnenblick EH, Anversa P, Leri A, Kajstura J: Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II-dependent. Lab Invest 80:513-527, 2000
15. 1 receptor and NADPH oxidase. Hypertension 42:206-212, 2003
16. Shimoni Y: Inhibition of the formation or action of angiotensin II reverses attenuated K+ currents in type 1 and type 2 diabetes. J Physiol (Lond) 37:83-92, 2001
17. Hoenack C, Roesen P: Inhibition of angiotensin type 1 receptor prevents decline of glucose transporter (GLUT4) in diabetic rat heart. Diabetes 45 (Suppl. 1):S82-S87, 1996
18. Czech MP, Corvera S: Signaling mechanisms that regulate glucose transport. J Biol Chem 274:1865-1868, 1999
19. Kishi K, Hayashi H, Wang L, Kamohara S, Tamaoka K, Shimizu T, Ushikubi F, Narumiya S, Ebina Y: Gq-coupled receptors transmit the signal for GLUT4 translocation via an insulin-independent pathway. J Biol Chem 271:26561-26568, 1996
20. De Paoli P, Raimondi L, Lonardo G, Pirisino R, Mugelli A, Cerbai E: Electrophysiological remodeling in the diabetic heart: prevention by angiotensin II receptor blockade (Abstract). Eur Heart J 4:671, 2002
21. Cerbai E, Barbieri M, Li Q, Mugelli A: Ionic basis of action potential prolongation of hypertrophied cardiac myocytes isolated from hypertensive rats of different ages. Cardiovasc Res 28:1180-1187, 1994
22. Cerbai E, Barbieri M, Mugelli A: Characterization of the hyperpolarization-activated current, I(f), in ventricular myocytes isolated from hypertensive rats. J Physiol (Lond) 481:585-591, 1994
23. Fischer Y, Rose H, Thomas J, Deuticke B, Kammermeier H: Phenylarsine oxide and hydrogen peroxide stimulate glucose transport via different pathways in isolated cardiac myocytes. Biochim Biophys Acta 1153:97-104, 1993
24. Cerbai E, Crucitti A, Sartiani L, De Paoli P, Pino R, Rodriguez ML, Gensini G, Mugelli A: Long-term treatment of spontaneously hypertensive rats with losartan and electrophysiological remodeling of cardiac myocytes. Cardiovasc Res 45:388-396, 2000
25. Cerbai E, De Paoli P, Sartiani L, Lonardo G, Mugelli A: Treatment with irbesartan counteracts the functional remodeling of ventricular myocytes from hypertensive rats. J Cardiovasc Pharmacol 41:804-812, 2003
26. Ha T, Kotsanas G, Wendt I: Intracellular Ca2+ and adrenergic responsiveness of cardiac myocytes in streptozotocin-induced diabetes. Clin Exp Pharmacol Physiol 26:347-353, 1999
27. Garvey WT, Hardin D, Juhaszova M, Dominguez JH: Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy. Am J Physiol 264:H837-H844, 1993
28. Qin D, Huang B, Deng L, El Adawi H, Ganguly K, Sowers JR, El Sherif N: Dowregulation of K+ channel genes expression in type I diabetic cardiomyopathy. Biochem Biophys Res Commun 283:549-553, 2001
29. Magyar J, Rusznak Z, Szentesi P, Szucs G, Kovacs L: Action potentials and potassium currents in rat ventricular muscle during experimental diabetes. J Mol Cell Cardiol 24:841-853, 1992
30. Pandit SV, Giles WR, Demir SS: A mathematical model of the electrophysiological alterations in rat ventricular myocytes in type I diabetes. Biophys J 84:832-841, 2003
31. Ishikawa T, Kajiwara H, Kurihara S: Alterations in contractile properties and Ca2+ handling in streptozotocin-induced diabetic rat myocardium. Am J Physiol 277:H2185-H2194, 1999
32. Naas AAO, Davidson NC, Thompson C, Cummings F, Ogston SA, Jung RT, Newton RW, Struthers AD: QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study. BMJ 316:745-746, 1998
33. Veglio M, Bruno G, Borra M, Macchia G, Bargero G, D'Errico N, Pagano GF, Cavallo-Perin P: Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population-based cohort. J Int Med 251:317-324, 2002
34. Sahu P, Lim PO, Rana BS, Struthers AD: QT dispersion in medicine. Electrophysiological holy grail or fool's gold? QJM 93:425-431, 2000
35. Whitsel EA, Boyko EJ, Siscovick DS: Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes: a metaanalysis. Diabetes Care 23:241-247, 2000
36. Rana BS, Band MM, Ogston S, Morris AD, Pringle SD, Struthers AD: Relation of QT interval dispersion to the number of different cardiac abnormalities in diabetes mellitus. Am J Cardiol 90:483-487, 2002
37. Lindholm LH, Dahlof B, Edelman JM, Ibsen H, Borch-Johnsen K, Olsen MH, Snapinn S, Wachtell K: Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study. Lancet 362:619-620, 2003
38. Fiordaliso F, Leri A, Cesselli D, Limana F, Safai B, Nadal-Ginard B, Anversa P, Kajstura J: Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 50:2363-2375, 2001
39. Malhotra A, Kang BPS, Cheung S, Opawumi D, Meggs LG: Angiotensin II promotes glucose-induced activation of cardiac protein kinase C isozymes and phosphorylation of troponin 1. Diabetes 50:1918-1926, 2001